Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory Drugs

Recent advances in immunotherapy have revolutionized cancer therapy. Immunotherapies can engage the adaptive and innate arms of the immune system. Therapeutics targeting immune checkpoint inhibitors (i.e., CTLA-4; PD-1, and PD-L1) have shown efficacy for subsets of cancer patients by unleashing an a...

Full description

Saved in:
Bibliographic Details
Main Authors: Dina V. Hingorani (Author), Maria F. Camargo (Author), Maryam A. Quraishi (Author), Stephen R. Adams (Author), Sunil J. Advani (Author)
Format: Book
Published: MDPI AG, 2021-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!